Original ResearchRace-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress?
Section snippets
Data
Our study employs data from the 2008–2013 National Immunization Survey-Teen (NIS-Teen). The National Center for Immunization and Respiratory Diseases and the National Center for Health Statistics collected the telephone survey data from a random digit sample of parents of adolescent children.33 The NIS-Teen survey implemented a dual-frame sampling design with independent landline and cell phone samples. Response rates for these samples averaged 56.4% and 23.1%, respectively. The primary aim of
Results
In the pooled sample, approximately 44% of females initiated the HPV vaccine, although the proportion is highest among Hispanic teens (48%) and lowest among African American adolescents (40%). Provider recommendations among females also appear to vary by race and ethnicity, ranging from approximately 52% among African Americans to 61% among non-Hispanic Whites. A slightly different trend exists among adolescent males. Only about 14% of teenage boys initiated the HPV vaccine, ranging from
Discussion
Recent scholarship suggests that rates of vaccine uptake have increased across racial and ethnic groups;30, 31 however, it is unclear whether racial and ethnic disparities in HPV vaccination uptake have changed over time. In addition to examining racial and ethnic trends in vaccination, we examined racial and ethnic variations in provider recommendation to vaccinate against HPV, as well as the role of these recommendations in explaining racial and ethnic disparities in vaccine uptake. Our
Ethical approval
The current study employs secondary data analysis, drawing on a large national sample of de-identified respondents. The National Immunization Survey-Teen is publicly available through the Centers for Disease Control and Prevention (http://www.cdc.gov/nchs/nis/data_files_teen.htm.); thus, this study did not require IRB review.
Funding
None declared.
Competing interests
None declared.
References (38)
Cervical cancer
Lancet
(2003)- et al.
Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States
Curr Problems Cancer
(2007) - et al.
Factors associated with HPV vaccine uptake in teenage girls: a systematic review
Vaccine
(2012) - et al.
Racial disparities in human papillomavirus vaccination: does access matter?
J Adolesc Health
(2013) - et al.
Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory
Soc Sci Med
(2013) - et al.
Worsening disparities in HPV vaccine utilization among 19–26 year old women
Vaccine
(2011) - et al.
Sociodemographic differences in human papillomavirus vaccine initiation by adolescent males
J Adolesc Health
(2015) - et al.
Social determinants of HPV vaccination delay rationales: evidence from the 2011 National Immunization Survey–Teen
Prev Med Rep
(2014) - et al.
Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012
Vaccine
(2015) - et al.
HPV vaccination among adolescent males: results from the National Immunization Survey-Teen
Vaccine
(2013)
Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000
Perspect Sex Reprod Health
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
J Pathol
United States cancer statistics: 1999–2012 incidence and mortality web-based report
Prevalence of HPV infection among females in the United States
J Am Med Assoc
A fourth of U.S. women aged 14–59 have a human papillomavirus infection
Perspect Sex Reprod Health
Prevalence of HPV infection among men: a systematic review of the literature
J Infect Dis
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
J Natl Cancer Inst
Prevalence of oral HPV infection in the United States, 2009–2010
J Am Med Assoc
Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)
Morb Mortal Wkly Rep
Cited by (48)
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California
2022, VaccineCitation Excerpt :For series completion the authors concluded that minorities were at a disadvantage compared to whites, although this disparity appeared to decrease over time [13]. Prior studies suggested that physician bias, differential deference to medical authority, social norm and vaccine hesitancy may be potential reasons behind these findings [14–16]. In our study we observed reverse disparity in an integrated system for both any dose and up-to-date coverage, adding to the evidence of this relatively unique phenomenon in preventive care uptake.
Beyond words: Parental perceptions on human papilloma virus vaccination recommendations and its impact on uptake
2021, Preventive Medicine ReportsThe impact of school-entry mandates on social inequalities in human papillomavirus vaccination
2020, SSM - Population HealthCitation Excerpt :Research documenting HPV vaccination inequalities suggests low (vs. high) SES and Black (vs. White) girls are less likely to receive a health provider recommendation (Polonijo & Carpiano, 2013) and the racial gap in recommendations has waned, but not disappeared, over time (Burdette et al., 2017). Inequalities in HPV vaccine uptake have also evolved over time (Burdette et al., 2017); recent estimates suggest lower (vs. higher) income and Black and Hispanic (vs. non-Hispanic White) adolescents are more likely to initiate vaccination, however lower SES and Black girls are less likely to complete the vaccine series and be fully protected (Reagan-Steiner et al., 2016; Walker et al., 2017). Hispanic adolescents—initially less likely to complete the HPV vaccine series—now have the highest completion rates (Reagan-Steiner et al., 2016).